Literature DB >> 2552911

In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin.

J D Treharne1, P J Yearsley, R C Ballard.   

Abstract

Although rapid emergence of antibiotic-resistant mutants of Chlamydia trachomatis occurs when the organism is grown in subinhibitory concentrations of rifampin, no such mutants could be demonstrated when the organism was propagated under the same conditions in subinhibitory levels of the related drug rifabutin.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2552911      PMCID： PMC172664          DOI： 10.1128/AAC.33.8.1393

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Emergence of rifampin-resistance in Chlamydia trachomatis.

Authors:  H Keshishyan; L Hanna; E Jawetz
Journal:  Nature       Date:  1973-07-20       Impact factor: 49.962

2.  Rifampicin, an antitrachoma antibiotic.

Authors:  Y Becker
Journal:  Isr J Med Sci       Date:  1972 Aug-Sep

3.  Rifampicin--a new antitrachoma drug.

Authors:  Y Becker; Z Zakay-Rones
Journal:  Nature       Date:  1969-05-31       Impact factor: 49.962

4.  Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs.

Authors:  R Cevenini; M Donati; V Sambri; F Rumpianesi; M La Placa
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

5.  In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.

Authors:  C L Woodley; J O Kilburn
Journal:  Am Rev Respir Dis       Date:  1982-09

6.  Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.

Authors:  W R Bowie; C K Lee; E R Alexander
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

7.  Sensitivity of mitomycin-C treated McCoy cells for isolation of Chlamydia trachomatis from genital specimens.

Authors:  R M Woodland; R P Kirton; S Darougar
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267
  7 in total
  8 in total

1.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

2.  Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.

Authors:  Andrei Kutlin; Stephan Kohlhoff; Patricia Roblin; Margaret R Hammerschlag; Paul Riska
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis.

Authors:  K Wolf; R Malinverni
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.

Authors:  Patricia M Roblin; Tamara Reznik; Andrei Kutlin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

5.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

6.  Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.

Authors:  Ute Dreses-Werringloer; Ingrid Padubrin; Lars Köhler; Alan P Hudson
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 7.  Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; A Fitton
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

Review 8.  Advances and Obstacles in the Genetic Dissection of Chlamydial Virulence.

Authors:  Julie A Brothwell; Matthew K Muramatsu; Guangming Zhong; David E Nelson
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.737
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.